Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Cefepime–Taniborbactam in Complicated Urinary Tract Infection

by Dorr, MaryBeth , Moeck, Greg , Gasink, Leanne B. , Dane, Aaron , McLeroth, Patrick , Wagenlehner, Florian M. , McGovern, Paul C. , Henkel, Tim

in Administration, Intravenous / Adult / Adverse events / Aged / Aging / Aging General / Anti-Bacterial Agents - administration & dosage / Anti-Bacterial Agents - adverse effects / Anti-Bacterial Agents - therapeutic use / Antibiotics / Bacteremia / Bacteremia - drug therapy / Bacteremia - microbiology / Bacterial Infections / beta-Lactamases - administration & dosage / beta-Lactamases - adverse effects / beta-Lactamases - therapeutic use / Borinic Acids - administration & dosage / Borinic Acids - adverse effects / Borinic Acids - therapeutic use / Carbapenems / Carboxylic Acids - administration & dosage / Carboxylic Acids - adverse effects / Carboxylic Acids - therapeutic use / Cefepime / Cefepime - administration & dosage / Cefepime - adverse effects / Cefepime - therapeutic use / Clinical Medicine / Clinical Medicine General / Clinical trials / Constipation / Diarrhea / Drug dosages / Drug Resistance, Bacterial / Drug Therapy, Combination / Enterobacterales / Enzymes / Geriatrics / Hospital-Based Clinical Medicine / Hospitalization / Humans / Infectious Disease / Infectious Disease General / Meropenem / Meropenem - administration & dosage / Meropenem - adverse effects / Meropenem - therapeutic use / Microbial Sensitivity Tests / Middle Aged / Multidrug resistance / Nephrology / Outpatient-Based Clinical Medicine / Pathogens / Patient safety / Patients / Pharmaceuticals / Prostate Disease / Prostate Disease General / Pseudomonas aeruginosa / Public health / Pyelonephritis / Pyelonephritis - drug therapy / Pyelonephritis - microbiology / Success / Urinary tract / Urinary tract diseases / Urinary tract infections / Urinary Tract Infections - drug therapy / Urinary Tract Infections - microbiology / Urogenital system / Urology / UTI / β Lactamase / β-Lactam antibiotics

2024

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Cefepime–Taniborbactam in Complicated Urinary Tract Infection

by Dorr, MaryBeth , Moeck, Greg , Gasink, Leanne B. , Dane, Aaron , McLeroth, Patrick , Wagenlehner, Florian M. , McGovern, Paul C. , Henkel, Tim

2024

Confirm

Do you wish to request the book?

Cefepime–Taniborbactam in Complicated Urinary Tract Infection

by Dorr, MaryBeth , Moeck, Greg , Gasink, Leanne B. , Dane, Aaron , McLeroth, Patrick , Wagenlehner, Florian M. , McGovern, Paul C. , Henkel, Tim

2024

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Cefepime–Taniborbactam in Complicated Urinary Tract Infection

Dorr, MaryBeth,

Moeck, Greg,

Gasink, Leanne B.,

Dane, Aaron,

McLeroth, Patrick,

Wagenlehner, Florian M.,

McGovern, Paul C.,

Henkel, Tim

2024

Overview

In patients with complicated urinary tract infection, clinical and microbiologic treatment success was significantly better with cefepime–taniborbactam (β-lactam and β-lactamase inhibitor) than with meropenem.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

Administration, Intravenous

/ Adult

/ Adverse events

/ Aged

/ Aging

/ Aging General

/ Anti-Bacterial Agents - administration & dosage